{"id":"W2117677020","doi":"10.1056/nejmoa1112277","title":"Rivaroxaban in Patients with a Recent Acute Coronary Syndrome","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1887,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Duke Clinical Research Institute; Genentech; Eisai; Symetis; Daiichi Sankyo Europe; Sanofi; Bayer HealthCare; Amarin Corporation; Medicure; Biogen; GlaxoSmithKline; Pfizer; IC Design Education Center; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Rivaroxaban; Acute coronary syndrome; Medicine; Cardiology; Internal medicine; Intensive care medicine; Myocardial infarction; Atrial fibrillation; Warfarin","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001553414,0.000393991,0.001429792,0.0002820836,0.0002935175,0.0004910691,0.0002473366,0.0007441534,0.001574694],"category_scores_gemma":[0.003428678,0.0001662351,0.001006376,0.0004899106,0.0002058488,0.0002821728,0.0002280007,0.001046893,0.0002647318],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002491385,"about_ca_system_score_gemma":0.0003650845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003322845,"about_ca_topic_score_gemma":0.0004798874,"domain_scores_codex":[0.9993155,0.0003247888,0.0001048295,0.00008642483,0.0001236414,0.00004479955],"domain_scores_gemma":[0.9985454,0.0004786038,0.0006027336,0.00005310309,0.00008622919,0.0002340249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1249977,0.004080122,0.6039492,0.005049378,0.00481277,0.004368383,0.0005113144,0.0009333949,0.01064839,0.0008469384,0.01022101,0.2295813],"study_design_scores_gemma":[0.06693038,0.04457754,0.8400743,0.001200916,0.004049329,0.01581795,0.0002823922,0.002111572,0.001932784,0.001223308,0.02171165,0.00008782618],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.92361,0.06751319,0.0005621492,0.00259525,0.0006425434,0.0003364335,0.0003869554,0.00002898907,0.004324443],"genre_scores_gemma":[0.9855466,0.0108072,0.0005439821,0.001318425,0.0008302573,0.0001815948,0.0003990272,0.000004292997,0.0003685782],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001574694,"threshold_uncertainty_score":0.008215368,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04840318230791097,"score_gpt":0.2845888985375182,"score_spread":0.2361857162296072,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}